Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
J Lasierra-Cirujeda, P Coronel, MJ Aza & M Gimeno. (2010) Use of sulodexide in patients with peripheral vascular disease. Journal of Blood Medicine 1, pages 105-114.
Read now
Read now
Articles from other publishers (13)
Xuewen Yang, Qiuxiang Wang, Aiwen Zhang, Xinyao Shao, Tianqing Liu, Bo Tang & Guihua Fang. (2022) Strategies for sustained release of heparin: A review. Carbohydrate Polymers 294, pages 119793.
Crossref
Crossref
Michael T. Kemp, Andrea T. Obi, Peter K. Henke & Thomas W. Wakefield. (2021) A narrative review on the epidemiology, prevention, and treatment of venous thromboembolic events in the context of chronic venous disease. Journal of Vascular Surgery: Venous and Lymphatic Disorders 9:6, pages 1557-1567.
Crossref
Crossref
Min Qiu, Shengjie Huang, Chuanhong Luo, Zhenfeng Wu, Binzhu Liang, Haozhou Huang, Zhimin Ci, Dingkun Zhang, Li Han & Junzhi Lin. (2021) Pharmacological and clinical application of heparin progress: An essential drug for modern medicine. Biomedicine & Pharmacotherapy 139, pages 111561.
Crossref
Crossref
D. A. Lavrentyev & A. E. Zotikov. (2020) Parnaparin in surgery, vascular surgery and associated disciplines. Aterotromboz = Atherothrombosis:2, pages 115-128.
Crossref
Crossref
I.A. Lapina, Yu.E. Dobrokhotova, T.G. Koltinova & V.V. Taranov. (2020) A modern approach to screening for thrombophilia and the prevention of venous thromboembolism during pregnancy. Problemy reproduktsii 26:4, pages 110.
Crossref
Crossref
A.S. Petrikov. (2020) Parnaparin sodium — modern therapy options and prevention of venous thromboembolic complications. Khirurgiya. Zhurnal im. N.I. Pirogova:11, pages 115.
Crossref
Crossref
Louise E See Hoe, Nicole Bartnikowski, Matthew A Wells, Jacky Y Suen & John F Fraser. (2019) Hurdles to Cardioprotection in the Critically Ill. International Journal of Molecular Sciences 20:15, pages 3823.
Crossref
Crossref
E. N. Petrova, Yu. S. Polushin, I. V. Shlyk & A. N. Tsed. (2019) Particulars of the perioperative management of patients with end stage renal disease during hip and knee replacement arthroplasty. Almanac of Clinical Medicine 47:3, pages 251-265.
Crossref
Crossref
Theodoros Aslanidis, Paschalia Karakosta & Athena Myrou. (2019) Anticoagulation during continuous renal replacement therapy: An update. Serbian Journal of Anesthesia and Intensive Therapy 41:5-6, pages 113-123.
Crossref
Crossref
Cui Hao, Mojian Sun, Hongmei Wang, Lijuan Zhang & Wei Wang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B
21
39
.
N. N. Drozd, S. A. Kuznetsova, E. Yu. Savchik, N. T. Miftakhova & N. Yu. Vasil’eva. (2015) Effects of Subcutaneous Microcrystalline Cellulose Sulfate Extracted from the Wood of the Siberian Fir (Abies sibirica Ledeb) on the Clotting of Rabbit Plasma. Pharmaceutical Chemistry Journal 49:3, pages 167-170.
Crossref
Crossref
B. COSMI, M. FILIPPINI, D. TONTI, G. AVRUSCIO, A. GHIRARDUZZI, E. BUCHERINI, G. CAMPORESE, D. IMBERTI & G. PALARETI. (2012) A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis 10:6, pages 1026-1035.
Crossref
Crossref
Giulia Angeloni, Silvia Alberti, Enrico Romagnoli, Alberto Banzato, Marco Formichi, Umberto Cucchini & Vittorio Pengo. (2010) Low molecular weight heparin (parnaparin) for cardioembolic events prevention in patients with atrial fibrillation undergoing elective electrical cardioversion: a prospective cohort study. Internal and Emergency Medicine 6:2, pages 117-123.
Crossref
Crossref